Determination of Risk Factors of Ventricular Arrhythmias (VAs) After Implantation of Continuous Flow Left Ventricular Assist Device With Continuous Flow Left Ventricular Assist Device (CF-LVAD)

Rennes University Hospital681 enrolled

Overview

Determination of risk factors of ventricular arrhythmias (VAs) after implantation of continuous flow left ventricular assist device in order to characterize which patient requires ICD implantation in primary prevention.

Study Type

OBSERVATIONAL

Enrollment

681

Conditions

Severe Cardiac Insufficiency

Interventions

Implantable cardioverter-defibrillatorOTHER

Collection of clinical, biological, hemodynamic and rhythmic data

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient above 18 years old * Patients with CF-LVAD with or without ICD Exclusion Criteria: * Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Locations (20)

CHU de Bordeaux

Bordeaux, France

Hospices Civils de Lyon - Hôpital Louis Pradel

Bron, France

Outcomes

Primary Outcomes

Occurrence of early VAs (<30 days post operatively) and late VAs (>30 days post operatively) in patient with CF-LVAD with or without ICD

Clinical, biological, hemodynamic and rhythmic data

Time frame: 30 days

Secondary Outcomes

Mortality in patients with CF-LVAD with or without VAs

Time frame: 30 days

Mortality in patients with CF-LVAD with or without ICD

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.